MacLeod Roderick H. 4
4 · NEVRO CORP · Filed Mar 4, 2025
Insider Transaction Report
Form 4
NEVRO CORPNVRO
MacLeod Roderick H.
SVP, Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-28+742→ 132,101 total - Tax Payment
Common Stock
2025-02-28$5.72/sh−805$4,605→ 130,904 total - Tax Payment
Common Stock
2025-03-02$5.72/sh−1,143$6,538→ 129,761 total - Tax Payment
Common Stock
2025-02-28$5.72/sh−392$2,242→ 131,709 total
Footnotes (2)
- [F1]Represents Performance Stock Units ("PSUs") initially granted on February 28, 2022 that were subject to a performance-based vesting condition. The Compensation Committee of the Issuer certified the achievement of the second milestone vesting condition upon which a portion of the PSUs vested.
- [F2]Includes 100,694 restricted stock units.